// App-Quantinova.ai

631 : From Phenomenology to Mechanism: Resistance to Annexin A5 Anticoagulant Activity Identifies a Subset of Patients with Antiphospholipid Antibodies and Thrombosis

Researchers

Presenter

  • Xiao Xuan Wu

Principal Investigators

  • Alan Arslan

  • Jacob H. Rand

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Placental insufficiency

  • Venous thrombosis

  • Renal disease

  • Solid malignancies

  • Stroke

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Phosphatidylserine

  • annexin A5

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved